This cc-Hck fusion protein causes the protein to oligomerize and become activated like the Bcr-Abl oncoprotein in CML, resulting in GM-CSF–independent growth and survival. The gene discussed is CSF2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.